Spot Trading’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-229
Closed -$21K 2997
2016
Q4
$21K Buy
229
+130
+131% +$11.2K ﹤0.01% 2553
2016
Q3
$8K Buy
+99
New +$8.31K ﹤0.01% 2909
2016
Q1
Sell
-5,170
Closed -$368K 3529
2015
Q4
$368K Sell
5,170
-988
-16% -$66.4K ﹤0.01% 2113
2015
Q3
$379K Sell
6,158
-1,939
-24% -$136K ﹤0.01% 2239
2015
Q2
$587K Buy
8,097
+887
+12% +$65.5K 0.01% 2008
2015
Q1
$554K Sell
7,210
-7,699
-52% -$551K 0.01% 2033
2014
Q4
$1M Buy
14,909
+5,793
+64% +$366K 0.01% 1882
2014
Q3
$553K Buy
9,116
+6,499
+248% +$400K ﹤0.01% 2485
2014
Q2
$154K Buy
+2,617
New +$153K ﹤0.01% 3497

Other funds holding DGX

Spot Trading's DGX Position: Q1 2017 in Review

Spot Trading sold out of Quest Diagnostics (DGX) in Q1 2017, closing a stake of 229 shares — an estimated $21K sold.

Spot Trading first reported a position in DGX in Q2 2014 and held it in 9 quarters. The position peaked at $1M in Q4 2014. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

  • Spot Trading reported no remaining Quest Diagnostics position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 229 Quest Diagnostics shares in Q1 2017, an estimated $21K.
  • Spot Trading first reported a position in Quest Diagnostics in Q2 2014 and held it in 9 quarters.
  • Spot Trading's Quest Diagnostics position peaked at $1M in Q4 2014.
  • 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.